N@N

SANTA CLARA, Calif.--([ BUSINESS WIRE ])--Agilent Technologies Inc. (NYSE:A) today launched additional [ Agilent SureFISH ] probes, creating the largest offering of oligonucleotide-based fluorescent in situ hybridization (FISH) assays on the market. Over 425 probes are now available from Agilent, including centromere probes for all 24 chromosomes, and 35 telomere probes.

"In just over two months we have dramatically increased the number of probes we offer, demonstrating our commitment to quickly expand this portfolio for our customers"

Agilent SureFISH probes are designed for specific, nonrepetitive regions of the genome, providing superior resolution as compared to other available technologies. Standard BAC probes are limited in their ability to detect small aberrations, as well as the ability to specifically target chromosomal regions containing repetitive sequences. Oligo FISH probes enable users to specifically target chromosomal regions with a fast turnaround a" hybridization in as little as four hours. An example of the power of oligo technology, Agilentas SureFISH product line is able to offer centromere probes not typically available in BAC format. This includes centromere probes for chromosomes 5, 13, 14, 19, 21 and 22.

aAgilent SureFISH probes provide high-quality results and have allowed us to reduce turnaround time and expense,a said Jennifer Laffin, Ph.D., F.A.C.M.G., assistant professor, department of pediatrics, University of Wisconsin School of Medicine, and public health director, Clinical Genetics Laboratories.

Oligo FISH probes target relevant regions for a wide range of constitutional and cancer applications.

aIn just over two months we have dramatically increased the number of probes we offer, demonstrating our commitment to quickly expand this portfolio for our customers,a said Robert Schueren, Agilent vice president and general manager, Genomics. aAgilent is excited to be the only company to offer an oligo FISH platform and other molecular analysis products, including SurePrint CGH+SNP microarrays, and HaloPlex and SureSelect next-gen sequencing products, delivering a full set of solutions for cytogenetic research needs.a

Agilentas SureFISH product line offers:

• Unique probes not available in BAC format.
• Higher resolution and smaller regions than BAC probes.
• Shorter hybridization (as fast as four hours).
• Next-generation sequencing verification for every probe (ensures specificity to the region of interest).

Customers can easily find and purchase SureFISH probes on the [ SureFISH website ], which enables them to search for probes based on chromosome location, cytoband or genes of interest. The chromosome browser also includes images of all probes hybridized at four and 14 hours, allowing users to see the probe performance prior to purchase.

For more information about Agilent SureFISH probes, visit [ www.agilent.com/genomics/SureFISH ].

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is the worldas premier measurement company and a technology leader in chemical analysis, life sciences, electronics and communications. The companyas 18,700 employees serve customers in more than 100 countries. Agilent had net revenues of $6.6 billion in fiscal 2011. Information about Agilent is available at [ www.agilent.com ].

NOTE TO EDITORS: Further technology, corporate citizenship and executive news is available at [ www.agilent.com/go/news ].